70
Views
11
CrossRef citations to date
0
Altmetric
Review

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma

, , &
Pages 5745-5754 | Published online: 01 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xin Yu, Lijun Xu, Yongqiang Zhou, Xiaorong Zhou, Lei Yang & Yan Zhou. (2023) NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma. Journal of Inflammation Research 16, pages 3799-3809.
Read now
Ewelina Grywalska, Marcin Pasiarski, Stanisław Góźdź & Jacek Roliński. (2018) Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. OncoTargets and Therapy 11, pages 6505-6524.
Read now

Articles from other publishers (9)

Hao Chi, Jinyan Yang, Gaoge Peng, Jinhao Zhang, Guobin Song, Xixi Xie, Zhijia Xia, Jinhui Liu & Gang Tian. (2023) Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity. Frontiers in Immunology 14.
Crossref
Marcos Paulo S. Damasio, Camila Sales Nascimento, Lidia M. Andrade, Vivian L. de Oliveira & Carlos Eduardo Calzavara-Silva. (2022) The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. Frontiers in Oncology 12.
Crossref
Daniela Pereira, Diana Martins & Fernando Mendes. (2022) Immunotherapy in Head and Neck Cancer When, How, and Why?. Biomedicines 10:9, pages 2151.
Crossref
Xin Feng, Tan Zhang, Jeff Chou, Liang Liu, Lance D. Miller, Christopher A. Sullivan & James D. Browne. (2021) Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA‐seq data defines B cell immunity‐related genes as a robust survival predictor . Head & Neck 44:2, pages 443-452.
Crossref
Nuttapong Ngamphaiboon, Teeranuch Chureemas, Teerada Siripoon, Lalida Arsa, Narumol Trachu, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Ekaphop Sirachainan & Noppadol Larbcharoensub. (2019) Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma. Medical Oncology 36:2.
Crossref
Sai Han, Ying Wang, Xuejiao Shi, Liju Zong, Lu Liu, Juan Zhang, Qiuhong Qian, Jing Jin, Yana Ma, Baoxia Cui, Xingsheng Yang, Beihua Kong & Youzhong Zhang. (2018) Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer. Experimental Cell Research 371:1, pages 222-230.
Crossref
Katrine Schneider, Christian Grønhøj, Christoffer Holst Hahn & Christian von Buchwald. (2018) Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials. Vaccine 36:45, pages 6594-6605.
Crossref
David Escors, María Gato-Cañas, Miren Zuazo, Hugo Arasanz, María Jesus García-Granda, Ruth Vera & Grazyna Kochan. (2018) The intracellular signalosome of PD-L1 in cancer cells. Signal Transduction and Targeted Therapy 3:1.
Crossref
Stefano Cavalieri, Licia Rivoltini, Cristiana Bergamini, Laura D. Locati, Lisa Licitra & Paolo Bossi. (2018) Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs. Cancer Treatment Reviews 65, pages 78-86.
Crossref